Categories AlphaGraphs, Consumer, Earnings, Health Care
Johnson & Johnson (JNJ) reports Q3 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday.
The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational growth of 9.9%
Net earnings of $3.6 billion or $1.37 per share increased by 3%, also topped the target that analysts had anticipated.
Most Popular
Hormel Foods (HRL) fine-tunes biz strategy to beat challenges. Is the stock a buy?
For consumer staples companies, rising inflation is probably turning into a bigger challenge than the virus-induced supply chain disruption and store closures. After bettering its position since the early months
HP Inc. (HPQ) stock research summary | Q3 2021
HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks
VMware Inc. (VMW) stock research summary | Q3 2021
In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware
